跳至主要内容
临床试验/NCT05418842
NCT05418842已完成不适用

Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial

Associacao de Investigacao de Cuidados de Suporte em Oncologia10 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2021年5月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
47
试验地点
10
主要终点
Functional Capacity

研究概览

简要总结

The main purpose of this randomized-controlled trial is to evaluate the effects of prehabilitation based on exercise training (ET) on functional capacity in HNC patients treated with chemoradiotherapy (CRT). Forty-six participants will be randomized (1:1 ratio) into prehabilitation and usual care groups. The length of intervention will be at least 2 weeks. Data will be collected at diagnosis, immediately before anti-cancer treatment start and 4 weeks following CRT. Primary outcome is functional capacity as assessed by the six-minute walk test. Additional measures include muscle strength, endothelial function, arterial stiffness, inflammatory biomarkers, body composition, quality of life, treatment tolerance, compliance to treatment, progression-free survival, and overall survival.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years old;
  • Histologically confirmed HNSCC located on the oral cavity, larynx, oropharynx, hypopharynx, nasopharynx or in lymph nodes from an unknown primary tumor (stage I-IV);
  • Proposed for concomitant chemoradiotherapy with curative intent;
  • Date of treatment beginning ≥2 weeks from baseline assessment;
  • ECOG-Performance Status 0-1.

排除标准

  • Completion of previous anticancer treatment within less than a year;
  • Uncontrolled hypertension, cardiac or pulmonary disease;
  • Contraindications to exercise training;
  • Inability to provide informed consent;
  • Expected inability to fulfil the proposed schedule.

结局指标

主要结局

Functional Capacity

时间窗: Change from Baseline (at diagnosis) to 1-3 days before the beginning of radiotherapy

Assessed by six-minute walk test.

次要结局

  • Functional Capacity(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Unplanned hospital visits(From baseline to 4 Weeks after last radiotherapy session)
  • Compliance to Chemotherapy(Through chemotherapy completion, an average of 7 weeks)
  • Compliance to Radiotherapy(Through radiotherapy completion, an average of 7 weeks)
  • Overall Survival(From baseline to 5 years after diagnosis)
  • Arterial Stiffness(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Endothelial Function(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Lower Limb Functionality(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Health-related Quality of Life(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Body Weight(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Percentage of Body Fat(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • C-Reactive Protein(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Albumin(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Hemogram(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Isometric Handgrip Muscle Strength(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Head and Neck Cancer-specific Quality of Life(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Muscle Mass(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Body Mass Index(Change from 1-3 days before the beginning of radiotherapy to 4 Weeks after last radiotherapy session)
  • Treatment-Related Adverse Events(From the beginning of radiotherapy/chemotherapy to 4 Weeks after last radiotherapy session)
  • Progression-Free Survival(From baseline to 5 years after diagnosis)

研究者

发起方
Associacao de Investigacao de Cuidados de Suporte em Oncologia
申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

Exercise Prehabilitation in Patients With Head and... | 临床试验